{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/NCEL",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# NewcelX Ltd. (NASDAQ: NCEL) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is NewcelX Ltd., listed on NASDAQ under ticker NCEL, with ISIN USH5835A1090. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-V8. The security type is non-operating entity type (other), the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is Switzerland. The segment is not on the record. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 54 filings in the twelve months to 2026-11-08, on 40 filing days. Filings comprise 23 results, 17 regulatory filings, 11 directors' dealings and 3 prospectuses. The median gap between filing days is 5 days. The latest filing is dated 2026-11-04, 4 days before the record date, and is a results filing. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. In sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days across 526 issuers. The issuer's filings count of 54 is above the NASDAQ median of 52 and below the sector median of 63.0.\n\n## Auditor\n\nThe auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, which foreign private issuers and older filings do not carry. The auditor location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds one lifecycle line: a delisting dated 2025-10-30. No listing, name change, domicile change or segment move is on the record. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is sealed. Sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001783036.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/NCEL (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/NCEL (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/NCEL",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://newcelx.com/investors/",
     "result": "not the issuer's own investor-relations page — not read"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "directors_dealings": 11,
    "prospectus": 3,
    "regulatory_filing": 17,
    "results": 23
   },
   "cadence_median_gap_days": 5,
   "filing_days": 40,
   "filings": 54,
   "latency_days": 4,
   "latest": [
    {
     "category": "6-K",
     "date": "2026-11-04",
     "source": "https://www.sec.gov/Archives/edgar/data/1783036/000121390026115753/ea0310650-6k_newcelx.htm",
     "title": "6-K — REPORT OF FOREIGN PRIVATE ISSUER",
     "type": "results"
    },
    {
     "category": "EFFECT",
     "date": "2026-09-22",
     "source": "https://www.sec.gov/Archives/edgar/data/1783036/999999999526003024/xslEFFECTX01/primary_doc.xml",
     "title": "EFFECT (items ,,)",
     "type": "regulatory_filing"
    },
    {
     "category": "POS AM",
     "date": "2026-09-18",
     "source": "https://www.sec.gov/Archives/edgar/data/1783036/000121390026101429/ea0305678-posam3_newcelx.htm",
     "title": "POS AM — POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-1",
     "type": "regulatory_filing"
    },
    {
     "category": "6-K",
     "date": "2026-09-18",
     "source": "https://www.sec.gov/Archives/edgar/data/1783036/000121390026101419/ea0305141-6k_newcelx.htm",
     "title": "6-K — REPORT OF FOREIGN PRIVATE ISSUER",
     "type": "results"
    },
    {
     "category": "EFFECT",
     "date": "2026-08-26",
     "source": "https://www.sec.gov/Archives/edgar/data/1783036/999999999526002774/xslEFFECTX01/primary_doc.xml",
     "title": "EFFECT (items ,,)",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-11-04",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/NCEL",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-08-05",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "USH5835A1090"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001783036.json",
    "state": "sourced",
    "value": "Switzerland"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-V8",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001783036.json",
    "state": "sourced",
    "value": "NewcelX Ltd."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001783036.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001783036.json",
    "state": "sourced",
    "value": "Non-operating entity type (other)"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NCEL"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [
    {
     "date": "2025-10-30",
     "source": "https://www.sec.gov/Archives/edgar/data/1783036/000135445725001077/xslF25X02/primary_doc.xml",
     "title": "25-NSE/A"
    }
   ],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:2b5be98bfa9fd9888255515874834702d1b8be23e31bbd54f4510ebf39cd484d",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/NCEL",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:2b5be98bfa9fd9888255515874834702d1b8be23e31bbd54f4510ebf39cd484d",
 "path": "/us/NASDAQ/NCEL",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is NewcelX Ltd., listed on NASDAQ under ticker NCEL, with ISIN USH5835A1090. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-V8. The security type is non-operating entity type (other), the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is Switzerland. The segment is not on the record. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 54 filings in the twelve months to 2026-11-08, on 40 filing days. Filings comprise 23 results, 17 regulatory filings, 11 directors' dealings and 3 prospectuses. The median gap between filing days is 5 days. The latest filing is dated 2026-11-04, 4 days before the record date, and is a results filing. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. In sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days across 526 issuers. The issuer's filings count of 54 is above the NASDAQ median of 52 and below the sector median of 63.0.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, which foreign private issuers and older filings do not carry. The auditor location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds one lifecycle line: a delisting dated 2025-10-30. No listing, name change, domicile change or segment move is on the record. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is sealed. Sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001783036.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/NCEL"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/NCEL"
  }
 ],
 "title": "NewcelX Ltd. (NCEL) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}